Reports showed that IFN-γcan stimulate the expression of PD-L1 in tumor cells, which bind with PD-1, inhibiting activation, expansion, and effector functions of CD8+ T cells, and helping cancer cells evade immune destruction to contribute to tumor immune evasion [40]. Here, CD8A is linked to cancer.